ReviewPathologie (Heidelberg, Germany)2026
[Hereditary cancer predisposition syndromes-significance of gynecological cancers].
Review in Pathologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A number of gynecologic cancers are associated with hereditary cancer syndromes (HCS). These neoplasms may represent the sentinel lesion for HCS within the affected individual/family. Many of these tumors exhibit distinctive histologic and immunohistochemical features that are associated with HCS tumors. By recognizing these features, pathologists may help in identifying HCS which is important regarding primary prevention efforts and personalized care for affected patients. This review summarizes morphologic features for HCS, such as BRCA, Lynch, Peutz-Jeghers, DICER1, rhabdoid tumor predisposition syndrome 2 (SMARCA4-deficiency), tuberous sclerosis, PTEN hamartoma tumor syndrome (Cowden), familiar adenomatous polyposis, and nevoid basal cell carcinoma syndrome.
Indexed as
Identifiers
42410002What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.